##### 



| |  |                |  |             
| |  | -------------- |  | ------------
| |  | CERTIFICATIONS |  | Exhibit 31.2

I, James M. Frates, certify that:

1.     I have reviewed this quarterly report on Form 10-Q of Alkermes Clinical
Partners, L.P.;

2.     Based on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this quarterly
report;

3.     Based on my knowledge, the financial statements, and other financial
information included in this quarterly report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this quarterly report;

4.     The other certifying officer of the General Partner and I are responsible
for establishing and maintaining disclosure controls and procedures (as defined
in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and we have:



| | a. |  | designed such disclosure controls and procedures, or caused
such disclosure controls and procedures to be designed under our
supervision, to ensure that material information relating to the
registrant, including its consolidated subsidiaries, is made known
to us by others within those entities, particularly during the
period in which this quarterly report is being prepared;
| | -- |  | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|
| | b. |  | evaluated the effectiveness of the registrants disclosure
controls and procedures and presented in this quarterly report our
conclusions about the effectiveness of the disclosure controls and
procedures, as of the end of the period covered by this quarterly
report based on such evaluation; and                                                                                 
|
| | c. |  | disclosed in this quarterly report any change in the
registrants internal control over financial reporting that occurred
during the registrants most recent fiscal quarter that has
materially affected, or is reasonably likely to materially affect,
the registrants internal control over financial reporting;                                                                    

5.     The other certifying officer of the General Partner and I have disclosed,
based on our most recent evaluation of internal control over financial
reporting, to the registrants auditors and the audit committee of registrants
board of directors (or persons performing the equivalent functions):



| | a. |  | all significant deficiencies and material weaknesses in the
design or operation of internal control over financial reporting
which are reasonably likely to adversely affect the registrants
ability to record, process, summarize and report financial
information; and
| | -- |  | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|
| | b. |  | any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrants internal control over
financial reporting.                                                                                               

|                      |  |                                                                                                                                           |  | 
|--------------------- |  | ----------------------------------------------------------------------------------------------------------------------------------------- |  | 
|Date: August 13, 2003 |  |                                                                                                                                           |  | 
|                      |  |                                                                                                                                           |  | 
|                      |  | /s/ James M. Frates                                                                                                                       |  | 
|                      |  |                                                                                                                                           |  | 
|                      |  | James M. Frates
Vice President and Chief Financial Officer of
Alkermes Development Corporation II, the 
General Partner of the Registrant |  |